Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: David S. who wrote (3352)	12/16/1997 10:54:00 PM
From: JOHN W.	Respond to of 6136

<along with a company with a single product on the market that is going to get new competition in late '98 early '99, AGPH.> Let me get this staright, better to have no products and revenues (VRTX) with a potential product-than to have one product. Gee, I guess the best thing for VRTX, is to continue to drag out the development even more, since 16 pills a day, kind of goes against this easier regimen move (i.e. Combivir).